130 related articles for article (PubMed ID: 25547995)
41. Endogenous adenosine modulation of 22Na uptake by rat brain synaptosomes.
Ribeiro JA; Lobo MG; Sebastião AM
Neurochem Res; 2003 Oct; 28(10):1591-5. PubMed ID: 14570405
[TBL] [Abstract][Full Text] [Related]
42. The adenosine deaminases of Plasmodium vivax and Plasmodium falciparum exhibit surprising differences in ligand specificity.
Ivanov A; Matsumura I
J Mol Graph Model; 2012 May; 35():43-8. PubMed ID: 22481078
[TBL] [Abstract][Full Text] [Related]
43. Regulation of adenosine concentration and cytoprotective effects of novel reversible adenosine deaminase inhibitors.
Barankiewicz J; Danks AM; Abushanab E; Makings L; Wiemann T; Wallis RA; Pragnacharyulu PV; Fox A; Marangos PJ
J Pharmacol Exp Ther; 1997 Dec; 283(3):1230-8. PubMed ID: 9399998
[TBL] [Abstract][Full Text] [Related]
44. Antitumor effect and antiangiogenic potential of the mTOR inhibitor temsirolimus against malignant pleural mesothelioma.
Moriya M; Yamada T; Tamura M; Ishikawa D; Hoda MA; Matsumoto I; Klepetko W; Oda M; Yano S; Watanabe G
Oncol Rep; 2014 Mar; 31(3):1109-15. PubMed ID: 24378576
[TBL] [Abstract][Full Text] [Related]
45. Low-toxicity immunosuppression by specific inhibition of adenosine deaminase (ADA): prolongation of mouse skin grafts with erythro-9-(2-hydroxy-3-nonyl) adenine hydrochloride (EHNA).
Lum CT; Sutherland DE; Foker JE; Najarian JS
Surg Forum; 1977; 28():320-2. PubMed ID: 364724
[No Abstract] [Full Text] [Related]
46. Adenosine deaminase inhibitors. Synthesis of deaza analogues of erythro-9-(2-hydroxy-3-nonyl)adenine.
Antonini I; Cristalli G; Franchetti P; Grifantini M; Martelli S; Lupidi G; Riva F
J Med Chem; 1984 Mar; 27(3):274-8. PubMed ID: 6699873
[TBL] [Abstract][Full Text] [Related]
47. Pharmacokinetics of inhibition of adenosine deaminase by erythro-9-(2-hydroxy-3-nonyl)adenine in CBA mice.
Lambe CU; Nelson DJ
Biochem Pharmacol; 1982 Feb; 31(4):535-9. PubMed ID: 7066021
[TBL] [Abstract][Full Text] [Related]
48. Phosphatidylinositol Induces Caspase-Independent Apoptosis of Malignant Pleural Mesothelioma Cells by Accumulating AIF in the Nucleus.
Kanemura S; Tsuchiya A; Kanno T; Nakano T; Nishizaki T
Cell Physiol Biochem; 2015; 36(3):1037-48. PubMed ID: 26112407
[TBL] [Abstract][Full Text] [Related]
49. The protonated form of 1-N6-etheno-[erythro-9-(2-hydroxy-3-nonyl)] adenine is identified at the active site of adenosine deaminase.
Caiolfa VR; Gill D; Parola AH
FEBS Lett; 1990 Jan; 260(1):19-22. PubMed ID: 2153576
[TBL] [Abstract][Full Text] [Related]
50. The flavonoid resveratrol suppresses growth of human malignant pleural mesothelioma cells through direct inhibition of specificity protein 1.
Lee KA; Lee YJ; Ban JO; Lee YJ; Lee SH; Cho MK; Nam HS; Hong JT; Shim JH
Int J Mol Med; 2012 Jul; 30(1):21-7. PubMed ID: 22552784
[TBL] [Abstract][Full Text] [Related]
51. Deficiency of Fyn protein is prerequisite for apoptosis induced by Src family kinase inhibitors in human mesothelioma cells.
Eguchi R; Kubo S; Takeda H; Ohta T; Tabata C; Ogawa H; Nakano T; Fujimori Y
Carcinogenesis; 2012 May; 33(5):969-75. PubMed ID: 22354875
[TBL] [Abstract][Full Text] [Related]
52. Regulation of thymocyte proliferation by endogenous adenosine and adenosine deaminase.
Sandberg G
Int J Immunopharmacol; 1983; 5(4):259-65. PubMed ID: 6605314
[TBL] [Abstract][Full Text] [Related]
53. Differential cardioprotection with selective inhibitors of adenosine metabolism and transport: role of purine release in ischemic and reperfusion injury.
Abd-Elfattah AS; Jessen ME; Lekven J; Wechsler AS
Mol Cell Biochem; 1998 Mar; 180(1-2):179-91. PubMed ID: 9546645
[TBL] [Abstract][Full Text] [Related]
54. Inhibition of adenosine deaminase attenuates inflammation in experimental colitis.
Antonioli L; Fornai M; Colucci R; Ghisu N; Da Settimo F; Natale G; Kastsiuchenka O; Duranti E; Virdis A; Vassalle C; La Motta C; Mugnaini L; Breschi MC; Blandizzi C; Del Taca M
J Pharmacol Exp Ther; 2007 Aug; 322(2):435-42. PubMed ID: 17488880
[TBL] [Abstract][Full Text] [Related]
55. Adenosine deaminase inhibitors. Synthesis and biological activity of deaza analogues of erythro-9-(2-hydroxy-3-nonyl)adenine.
Cristalli G; Franchetti P; Grifantini M; Vittori S; Lupidi G; Riva F; Bordoni T; Geroni C; Verini MA
J Med Chem; 1988 Feb; 31(2):390-3. PubMed ID: 3339608
[TBL] [Abstract][Full Text] [Related]
56. Proteomic differential display analysis identified upregulated astrocytic phosphoprotein PEA-15 in human malignant pleural mesothelioma cell lines.
Kuramitsu Y; Miyamoto H; Tanaka T; Zhang X; Fujimoto M; Ueda K; Tanaka T; Hamano K; Nakamura K
Proteomics; 2009 Nov; 9(22):5078-89. PubMed ID: 19771552
[TBL] [Abstract][Full Text] [Related]
57. Inhibition of epidermal growth factor receptor signaling in malignant pleural mesothelioma.
Jänne PA; Taffaro ML; Salgia R; Johnson BE
Cancer Res; 2002 Sep; 62(18):5242-7. PubMed ID: 12234991
[TBL] [Abstract][Full Text] [Related]
58. Effect of adenosine deaminase inhibition upon human lymphocyte blastogenesis.
Carson DA; Seegmiller JE
J Clin Invest; 1976 Feb; 57(2):274-82. PubMed ID: 176177
[TBL] [Abstract][Full Text] [Related]
59. The role of adenosine in chondrocyte death in murine osteoarthritis and in a murine chondrocyte cell line.
Mistry D; Chambers MG; Mason RM
Osteoarthritis Cartilage; 2006 May; 14(5):486-95. PubMed ID: 16443378
[TBL] [Abstract][Full Text] [Related]
60. Ponatinib is a potential therapeutic approach for malignant pleural mesothelioma.
Yang YW; Marrufo A; Chase J; Woodard GA; Jablons DM; Lemjabbar-Alaoui H
Exp Lung Res; 2021 Feb; 47(1):9-25. PubMed ID: 33107354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
